Form D · Other

Zyme Holdings, Inc.

Redwood Shores, CA · CIK 0001710689

Offering snapshot reported Aug 2, 2017 · SEC filing

Reported sold
$4.91M
Indefinite offering
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 20, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 2, 2017Initial$4,906,963No comparison9SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-291965
Total amount sold includes options granted times the exercise price.
Interests in a Stock Incentive Plan

Source: Form D, filed Aug 2, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Adam Berger Director
Ross Devor Director
Edward Dimbero Executive
Ryan Hinkle Director
Chandran Sankaran Director, Executive

Issuer details

Industry: Other (See others in industry)

Address:
240 Twin Dolphin Drive, Suite D
Redwood Shores, CA, 94065